Ligand Pharmaceuticals Inc (NASDAQ:LGND)

98.60
Delayed Data
As of Jul 02
 +1.51 / +1.56%
Today’s Change
41.99
Today|||52-Week Range
102.24
+85.30%
Year-to-Date

Today’s Trading

Previous close97.09
Today’s open96.83
Day’s range96.13 - 98.66
Volume243,225
Average volume (3 months)433,958
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+75.99%
Earnings growth (next 5 years)+46.08%
Revenue growth (last year)+31.78%
P/E ratio196.5
Price/Sales17.67
Price/Book73.34

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.40+1.30%
SAGESAGE Therapeutics In...-0.35-0.51%
THRXTheravance Inc-0.55-3.16%
GLPGGalapagos NV-1.64-3.13%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$1.05
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers